ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Atropos Health Launches the Atropos Evidence™ Agent at Stanford Health Care and Collaborates with Microsoft to Improve Evidence-Based Personalized Medicine at the Point of Care

The Atropos Evidence Agent, a best-in-class agentic AI solution for real-world evidence generation will collaborate with Microsoft to provide personalized clinical evidence at the point of care through Dragon Copilot

Atropos Health, a pioneer in translating real-world clinical data into personalized real-world evidence (RWE) and insights, today announced the Atropos Evidence™ Agent, an expert agent in generating real-world evidence (RWE). Atropos Health is now embedding personalized evidence within the EHR at Stanford Health Care with data from ChatEHR to provide improved personalized RWE at point of care. As part of a pilot with Microsoft, Atropos Health will combine ambient encounter data from Dragon Copilot with the Atropos Evidence™ Agent.

The Atropos Evidence™ Agent generates personalized RWE embedded in the EHR. The Atropos Evidence Agent accesses the patient record and patient level information such as “reason for visit” via ChatEHR, Stanford Health Care’s AI tool that translates patient records into plain language. Based on the data, the Agent generates RWE in order to provide documentation for treatment options or other care decisions - without the physician ever needing to ask a question. The RWE from the agent is integrated into the EHR, allowing the physician to save time by staying in the workflow. Atropos Health and Microsoft plan to take this collaboration further and pilot deeper direct integration into the Dragon Copilot ambient workflow.

“Utilizing agentic AI to embed real-world evidence (RWE) into workflows with patient-specific insights will enable providers to proactively address patient questions with speed and accuracy.” said Dr. Michael Pfeffer Chief Information and Digital Officer at Stanford Medicine. “This example shows how ambient AI, ChatEHR and agentic AI are putting technology to work for the benefit of both providers and patients.”

This expert RWE agent is now available to all US–based health systems for integration into their physician workflow. See a demo here.

"We built the Atropos Evidence Agent with the same rigor we apply to all our solutions prior to deploying within a health system,” said Dr. Brigham Hyde, CEO and co-founder at Atropos Health. "We have strong guardrails in place to ensure quality and accuracy for the patient specific personalized evidence generated by the Atropos Evidence Agent. This integration at Stanford Health Care is one example of improving the physician experience with agentic AI and we are continuing to innovate and invest in AI technology to close the evidence gap in medicine."

“We are in a moment in the technology industry where AI is helping to address many of healthcare’s most urgent problems," said Peter Durlach, CVP, Chief Strategy Officer, Microsoft Health & Life Sciences. “By collaborating with Atropos Health, we are working to help healthcare providers unlock new levels of productivity, reduce administrative burden and empower them to leverage new clinical decision making capabilities in the care of their patients.”

Customers rely on Atropos Health’s portfolio of evidence-generation tools through the federated installation of GENEVA OS® in their internal cloud data environment. In addition to the Green Button®, GENEVA OS customers can access Alexandria®, a collection of over 100,000 existing studies, including active clinical trial designs. The existing studies in Alexandria can be rerun on local data, generating novel content and evidence for customer use.

In addition to today's announcement of the Atropos Evidence Agent, Atropos Health is also announcing the availability of a no cost trial to US-based clinicians to answer clinical questions with evidence.

About Atropos Health

Atropos Health is the developer of GENEVA OS®, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improve individual patient outcomes with data-driven care, expedite research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant, real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com, connect through LinkedIn, or follow on X @AtroposHealth.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+0.00 (0.00%)
AAPL  268.47
+0.00 (0.00%)
AMD  233.54
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  279.70
+0.00 (0.00%)
META  621.71
+0.00 (0.00%)
MSFT  496.82
+0.00 (0.00%)
NVDA  188.15
+0.00 (0.00%)
ORCL  239.26
+0.00 (0.00%)
TSLA  429.52
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.